Hassan F. Abdallah is a distinguished Healthcare Executive with a robust and dynamic career spanning over a decade. He is widely recognized for his exceptional achievements in the realm of Regulatory Compliance and Healthcare Transactions. Hassan is a visionary leader with an outstanding track record of establishing and delivering effective compliance services for both external clients and healthcare organizations.
By: C
Dr. Sharlee More is excited to use her knowledge and experience to assist MCRA clients with critical toxicology assessments throughout the medical device lifecycle.
Dr. Sussman develops and executes biocompatibility services, including Biological Evaluation Plans (BEP) and Reports (BER), and biocompatibility sections in US regulatory submissions (510(k), De Novo, IDE, PMA and combination product) and international regulatory submissions. This work includes strategy, design, implementation, analysis, and review of biocompatibility evaluations including biological testing, chemical characterization, and toxicological risk assessments. Prior to joining MCRA in 2022, Dr.
Dr. Soendergaard is a highly accomplished scientist with multiple peer reviewed publications, research grants, patents, and presentations at international meeting. His combined background in industry and academia gives him a unique perspective from the client’s point of view and he is acutely aware of the many challenges and constraints clients are constantly faced with in bringing and keeping new products on the market.
MCRA is pleased to announce its role in the successful Premarket Approval (PMA) application decision by the U.S.
MCRA's world class know-how and execution unlocks barriers, advancing our clients mission to better the availability of quality medical care to patients around the world.
